HighTower Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$110 3969
2024
Q3
$110 Buy
+100
New +$7.47K ﹤0.01% 3718
2014
Q3
Sell
-25,806
Closed -$37K 1613
2014
Q2
$37K Hold
25,806
﹤0.01% 1525
2014
Q1
$37K Buy
25,806
+2,468
+11% +$113K ﹤0.01% 1440
2013
Q4
$9K Sell
23,338
-561
-2% -$25.1K ﹤0.01% 1514
2013
Q3
$8K Buy
+23,899
New +$1.03M ﹤0.01% 1331

Other funds holding MET

HighTower Advisors's MET Position: Q1 2026 in Review

HighTower Advisors increased its MetLife (MET) stake by 16% in Q1 2026, buying an estimated $1.64M and bringing the position to 161,633 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #816.

HighTower Advisors first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $60.4M in Q4 2023. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • HighTower Advisors held 161,633 shares of MetLife worth $11.4M as of Q1 2026.
  • HighTower Advisors bought 21,898 MetLife shares in Q1 2026, an estimated $1.64M.
  • MetLife made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #816 holding.
  • HighTower Advisors first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's MetLife position peaked at $60.4M in Q4 2023.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.